ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $136,899 | -19.7% | 25,119 | -1.2% | 0.01% | -23.1% |
Q2 2023 | $170,561 | -24.0% | 25,419 | 0.0% | 0.01% | -23.5% |
Q1 2023 | $224,450 | +15.6% | 25,419 | 0.0% | 0.02% | -5.6% |
Q4 2022 | $194,201 | -0.4% | 25,419 | -7.0% | 0.02% | -5.3% |
Q3 2022 | $195,000 | -13.3% | 27,338 | -1.5% | 0.02% | -13.6% |
Q2 2022 | $225,000 | -49.9% | 27,752 | -14.2% | 0.02% | -47.6% |
Q1 2022 | $449,000 | -54.7% | 32,338 | -8.5% | 0.04% | -48.8% |
Q4 2021 | $992,000 | -36.6% | 35,338 | -23.2% | 0.08% | -41.4% |
Q3 2021 | $1,565,000 | -16.8% | 46,038 | 0.0% | 0.14% | -18.1% |
Q2 2021 | $1,881,000 | -4.7% | 46,038 | -6.1% | 0.17% | -20.8% |
Q1 2021 | $1,974,000 | +10.3% | 49,038 | +61.9% | 0.22% | +5.9% |
Q4 2020 | $1,790,000 | -9.6% | 30,280 | -25.6% | 0.20% | -24.7% |
Q3 2020 | $1,980,000 | -15.1% | 40,710 | -15.6% | 0.27% | -22.6% |
Q2 2020 | $2,332,000 | +74.2% | 48,210 | 0.0% | 0.35% | +37.8% |
Q1 2020 | $1,339,000 | +492.5% | 48,210 | +539.6% | 0.25% | +535.0% |
Q4 2019 | $226,000 | -2.6% | 7,538 | +0.5% | 0.04% | -11.1% |
Q3 2019 | $232,000 | – | 7,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
Triatomic Management LP | 102,889 | $560,745 | 0.39% |